rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1989-6-5
|
pubmed:abstractText |
In a double-blind study performed in 81 healthy volunteers, 10 mg cetirizine and 60 mg terfenadine given orally in a single administration significantly inhibited skin reactivity to histamine. Astemizole (10 mg) was completely ineffective. The inhibitory effect of cetirizine was potent and regular whereas 6/28 (21%) volunteers did not respond to terfenadine. The difference observed between cetirizine and terfenadine might be due to differences in the metabolism of the two drugs after administration: terfenadine is rapidly and extensively metabolized whereas cetirizine is directly active without the need for biotransformation and, indeed is poorly metabolized.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-0605
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
24-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2565265-Adult,
pubmed-meshheading:2565265-Astemizole,
pubmed-meshheading:2565265-Benzhydryl Compounds,
pubmed-meshheading:2565265-Benzimidazoles,
pubmed-meshheading:2565265-Cetirizine,
pubmed-meshheading:2565265-Double-Blind Method,
pubmed-meshheading:2565265-Histamine,
pubmed-meshheading:2565265-Histamine H1 Antagonists,
pubmed-meshheading:2565265-Humans,
pubmed-meshheading:2565265-Hydroxyzine,
pubmed-meshheading:2565265-Skin,
pubmed-meshheading:2565265-Terfenadine
|
pubmed:articleTitle |
Pharmacological modulation of cutaneous reactivity to histamine: a double-blind acute comparative study between cetirizine, terfenadine and astemizole.
|
pubmed:affiliation |
UCB sa, Chemin du Foriest, Braine l'Alleud, Belgium.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|